Dialogue on Dissemination Summary PresentationLenora Johnson, M.P.H., C.H.E.S.

Center for Strategic Dissemination

Jon F. Kerner, Ph.D.

Division of Cancer Control & Population Sciences

The Dialogue ProcessAugust Call – Aims Identified

• A Dissemination Research agenda

• A Dissemination Implementation agenda (including the identification of dissemination tools that will have the greatest immediate payoff in reducing the suffering and death due to cancer)

• An inter-organizational collaboration agenda (focused on facilitating the Research and Implementation agendas)

• Case studies of successes

Context Specific Meetings

November 15-16, 2004

Dissemination Agendas for Public

Health

December 1-2, 2004

Dissemination Agendas for Clinical Care

Research Recommendations

Two Recommendations Seven Strategies

Expand Infrastructure and Support for Dissemination and Implementation Research

• Strategy 1: Reconstruct and Expand National Funding Mechanisms/Requirements

• Strategy 2: Improve Quality of Peer Review

• Strategy 3: Increase Incentives and Rewards for Training and Career Development

• Strategy 4: Develop Common Lexicon of Research Methods and Terminology

• Strategy 5: Broaden/Shift the Accepted Research Designs and Methodologies

• Strategy 6: Increase Study of Specific Areas of Dissemination and Implementation

• Strategy 7: Monitor Progress of Dissemination/Implementation and Present Evidence to Promote New Research Strategies

Build Body of Conceptual Models, Research Methods, and Theory-Based Applications

Implementation Recommendations

Two Recommendations Five Strategies

Effective Communications

• Strategy 1: Facilitate communication and interaction among parties who can benefit from the successful translation of cancer control research findings into practice.

• Strategy 5: Make evidence-based practices and “knowledge mobilization” methods easier to adopt.

Promote Partnerships

• Strategy 2: Promote research/practice partnerships between agencies that fund cancer control research and agencies that fund cancer control programs.

• Strategy 3: Increase demand for and encourage a culture of evidence-based practice within organizations that implement cancer control activities.

• Strategy 4: Cultivate dissemination partnerships based on mutual self-interest with traditional and non-traditional organizations.